NM_005169.4:c.509G>A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_005169.4(PHOX2A):c.509G>A(p.Cys170Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005169.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHOX2A | NM_005169.4 | c.509G>A | p.Cys170Tyr | missense_variant | Exon 3 of 3 | ENST00000298231.5 | NP_005160.2 | |
PHOX2A | NM_001425096.1 | c.593G>A | p.Cys198Tyr | missense_variant | Exon 3 of 3 | NP_001412025.1 | ||
PHOX2A | NM_001425097.1 | c.533G>A | p.Cys178Tyr | missense_variant | Exon 3 of 3 | NP_001412026.1 | ||
PHOX2A | NM_001425098.1 | c.*388G>A | 3_prime_UTR_variant | Exon 3 of 3 | NP_001412027.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHOX2A | ENST00000298231.5 | c.509G>A | p.Cys170Tyr | missense_variant | Exon 3 of 3 | 1 | NM_005169.4 | ENSP00000298231.5 | ||
PHOX2A | ENST00000546310.1 | c.85-176G>A | intron_variant | Intron 1 of 1 | 5 | ENSP00000444845.1 | ||||
PHOX2A | ENST00000544057.1 | n.377G>A | non_coding_transcript_exon_variant | Exon 3 of 3 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1378958Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 680238
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.509G>A (p.C170Y) alteration is located in exon 3 (coding exon 3) of the PHOX2A gene. This alteration results from a G to A substitution at nucleotide position 509, causing the cysteine (C) at amino acid position 170 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.